User profiles for Scott A. Halperin
Scott HalperinDalhousie University Verified email at dal.ca Cited by 23717 |
[HTML][HTML] Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in …
SA Halperin, L Ye, D MacKinnon-Cameron, B Smith… - The Lancet, 2022 - thelancet.com
Background The Ad5-nCoV vaccine is a single-dose adenovirus type 5 (Ad5) vectored vaccine
expressing the SARS-CoV-2 spike protein that was well-tolerated and immunogenic in …
expressing the SARS-CoV-2 spike protein that was well-tolerated and immunogenic in …
Pertussis is a frequent cause of prolonged cough illness in adults and adolescents
LD Senzilet, SA Halperin, JS Spika… - Clinical infectious …, 2001 - academic.oup.com
Although pertussis is increasingly recognized as a cause of prolonged cough illness in
adolescents and adults, its prevalence is not well established. We evaluated pertussis infection in …
adolescents and adults, its prevalence is not well established. We evaluated pertussis infection in …
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial
…, DW Scheifele, TR Kollmann, SA Halperin… - Jama, 2013 - jamanetwork.com
Importance Global use of human papillomavirus (HPV) vaccines to prevent cervical cancer
is impeded by cost. A 2-dose schedule for girls may be possible. Objective To determine …
is impeded by cost. A 2-dose schedule for girls may be possible. Objective To determine …
A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate …
SA Halperin, G Van Nest, B Smith, S Abtahi, H Whiley… - Vaccine, 2003 - Elsevier
Certain oligodeoxynuclotides with CpG motifs provide enhanced immune response to co-delivered
antigens. We performed a phase I, observer-blinded, randomized study in healthy …
antigens. We performed a phase I, observer-blinded, randomized study in healthy …
The changing and dynamic epidemiology of meningococcal disease
SA Halperin, JA Bettinger, B Greenwood, LH Harrison… - Vaccine, 2012 - Elsevier
The epidemiology of invasive meningococcal disease continues to change rapidly, even in
the three years since the first Meningococcal Exchange Meeting in 2008. Control of disease …
the three years since the first Meningococcal Exchange Meeting in 2008. Control of disease …
Morbidity of pertussis in adolescents and adults
…, MD Fradet, L Rochette, SA Halperin - The Journal of …, 2000 - academic.oup.com
The effect of age on the clinical presentation of pertussis was assessed in 664 adolescent
and adult cases. Complications were more frequent in adults than in adolescents (28% vs. 16…
and adult cases. Complications were more frequent in adults than in adolescents (28% vs. 16…
Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program—Active (IMPACT)
SA Halperin, EEL Wang, B Law, E Mills… - Clinical infectious …, 1999 - academic.oup.com
To assess the morbidity associated with the continued high levels of pertussis, we studied
all children .2 years of age who were admitted to the 11 Immunization Monitoring Program-…
all children .2 years of age who were admitted to the 11 Immunization Monitoring Program-…
Reducing pain during vaccine injections: clinical practice guideline
…, LM Bucci, P Mousmanis, E Lang, SA Halperin… - Cmaj, 2015 - Can Med Assoc
… Scott Halperin declares grants from GlaxoSmithKline, Sanofi, Novartis, Pfizer, Merck,
PREVENT (Pan-Provincial Vaccine Enterprise Inc.), Immunovaccine, Novavax, Janssen and Folia …
PREVENT (Pan-Provincial Vaccine Enterprise Inc.), Immunovaccine, Novavax, Janssen and Folia …
Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers
Background . Group A streptococcus (GAS) causes illness ranging from uncomplicated
pharyngitis to life-threatening necrotizing fasciitis, toxic shock, and rheumatic fever. Attempts to …
pharyngitis to life-threatening necrotizing fasciitis, toxic shock, and rheumatic fever. Attempts to …
Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory …
SA Halperin, B Ward, C Cooper, G Predy… - Vaccine, 2012 - Elsevier
BACKGROUND: The currently licensed aluminum-hydroxide-adjuvanted hepatitis B vaccines
require three doses over a 6-month period to achieve high rates of protection in adults. We …
require three doses over a 6-month period to achieve high rates of protection in adults. We …